HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

carfilzomib

an antineoplastic agent that inhibits the ubiquitin-proteasome pathway; structure in first source
Networked: 153 relevant articles (27 outcomes, 42 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Vij, Ravi: 14 articles (11/2015 - 06/2011)
2. Siegel, David S: 13 articles (10/2015 - 06/2012)
3. Jagannath, Sundar: 11 articles (11/2015 - 06/2011)
4. Wang, Michael: 10 articles (10/2015 - 06/2012)
5. Jakubowiak, Andrzej J: 10 articles (10/2015 - 06/2012)
6. Kirk, Christopher J: 9 articles (09/2014 - 05/2009)
7. Stewart, A Keith: 8 articles (04/2015 - 11/2009)
8. Lonial, Sagar: 8 articles (09/2014 - 06/2011)
9. Orlowski, Robert Z: 8 articles (10/2013 - 11/2007)
10. Niesvizky, Ruben: 6 articles (10/2015 - 01/2013)

Related Diseases

1. Multiple Myeloma
2. Neoplasms (Cancer)
3. Peripheral Nervous System Diseases (PNS Diseases)
4. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. Proteasome Endopeptidase Complex (Proteasome)
2. bortezomib (Velcade)
3. lenalidomide (CC 5013)
4. pomalidomide
5. Dexamethasone (Maxidex)
6. Thalidomide (Thalomid)
7. LBH589
8. Cyclophosphamide (Cytoxan)
9. benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
10. cyclopentenyl cytosine

Related Therapies and Procedures

1. Stem Cell Transplantation
2. Drug Therapy (Chemotherapy)
3. Renal Dialysis (Hemodialysis)
4. Transplants (Transplant)
5. Aftercare (After-Treatment)